PT  - JOURNAL ARTICLE
AU  - Rasmussen, Marie Isabel
AU  - Lühr Hansen, Mathias
AU  - Pichler, Gerhard
AU  - Dempsey, Eugene
AU  - Pellicer, Adelina
AU  - EL-Khuffash, Afif
AU  - Shashidhar, A
AU  - Piris-Borregas, Salvador
AU  - Alsina, Miguel
AU  - Cetinkaya, Merih
AU  - Chalak, Lina
AU  - Ozkan, Hilal
AU  - Baserga, Mariana
AU  - Sirc, Jan
AU  - Fuchs, Hans
AU  - Ergenekon, Ebru
AU  - Arruza, Luis
AU  - Mathur, Amit
AU  - Stocker, Martin
AU  - Vaccarello, Olalla Otero
AU  - Szczapa, Tomasz
AU  - Sarafidis, Kosmas
AU  - Krolak-Olejnik, Barbara
AU  - Memisoglu, Asli
AU  - Reigstad, Hallvard
AU  - Rafińska-Ważny, Elżbieta
AU  - Hatzidaki, Eleftheria
AU  - Peng, Zhang
AU  - Gkentzi, Despoina
AU  - Viellevoye, Renaud
AU  - De Buyst, Julie
AU  - Mastretta, Emmanuele
AU  - Wang, Ping
AU  - Hahn, Gitte Holst
AU  - Bender, Lars
AU  - Cornette, Luc
AU  - Tkaczyk, Jakub
AU  - Rio, Ruth del
AU  - Fumagalli, Monica
AU  - Papathoma, Evangelina
AU  - Wilinska, Maria
AU  - Naulers, Gunnar
AU  - Sadowska-Krawczenko, Iwona
AU  - Lecart, Chantal
AU  - Couce, María Luz
AU  - Fredly, Siv
AU  - Heuchan, Anne Marie
AU  - Karen, Tanja
AU  - Greisen, Gorm
TI  - Extremely preterm infant admissions within the SafeBoosC-III consortium during the COVID-19 lockdown
AID  - 10.1101/2020.10.02.20204578
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.02.20204578
4099  - http://medrxiv.org/content/early/2020/10/05/2020.10.02.20204578.short
4100  - http://medrxiv.org/content/early/2020/10/05/2020.10.02.20204578.full
AB  - Objective To evaluate if the number of admitted extremely preterm (EP) infants (born before 28 weeks of gestational age) has changed in the neonatal intensive care units (NICUs) of the SafeBoosC-III consortium during the global lockdown when compared to the corresponding time period in 2019.Design This is a retrospective, observational study. Forty-six out of 79 NICUs (58%) from 17 countries participated. Principal investigators were asked to report the following information: 1) Total number of EP infant admissions to their NICU in the three months where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic, 2) Similar EP infant admissions in the corresponding three months of 2019, 3) the level of local restrictions during the lockdown period and 4) the local impact of the COVID-19 lockdown on the everyday life of a pregnant woman.Results There was no significant difference between the number of EP infant admissions during the three most rigorous lockdown months of the COVID-19 pandemic compared to the corresponding three months in 2019 (n=428 versus n=457 respectively, p=0.33). There were no significant changes within individual geographic regions and no significant association between the level of lockdown restrictions and change in the number of EP infant admissions (p=0.334).Conclusion This larger ad hoc study did not confirm previous studies’ report of a major reduction in the number of extremely preterm births during the first phase of the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04527601Clinical Protocols https://clinicaltrials.gov/ct2/show/NCT04527601 Funding StatementThe sponsor/coordinating investigator, Professor of Paediatrics Gorm Greisen, is the initiator of the SafeBoosC-III project. He has no financial interest in the results of the trial. The Elsass Foundation, Aage and Johanne Louis-Hansen Foundation, and Svend Andersen Foundation supported the SafeBoosC-III trial through unconditional and unrestricted grants of DKK 2,700,000, DKK 1,000,000 and DKK 1,000,000, respectively. These funding sources had no role in the design of this study and will not have any role during its execution, analysis, interpretation of the data or decision to submit results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:According to Danish law, ethical permission to conduct this study was not necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analysed during the current study are available from the corresponding author on request and will be published on www.safeboosc.eu